MORGAN STANLEY - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 71 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$318,326
-21.7%
84,213
+38.8%
0.00%
Q2 2023$406,549
-37.3%
60,679
-39.1%
0.00%
Q1 2023$648,436
-14.8%
99,606
+11.6%
0.00%
Q4 2022$760,996
+158.0%
89,214
+59.0%
0.00%
Q3 2022$295,000
-70.7%
56,095
-76.4%
0.00%
Q2 2022$1,008,000
-25.6%
237,607
-38.4%
0.00%
Q1 2022$1,355,000
-85.4%
385,947
-72.3%
0.00%
-100.0%
Q4 2021$9,263,000
+45.3%
1,390,910
+117.8%
0.00%0.0%
Q3 2021$6,374,000
+1462.3%
638,701
+4729.9%
0.00%
Q2 2021$408,000
+270.9%
13,224
+459.2%
0.00%
Q4 2020$110,0002,3650.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders